Novel compounds
OwnerJoelle Thonnardinventor
Life of this patent
Estimating the term…
Abstract
The invention provides BASB223 and BASB224 polypeptides and polynucleotides encoding BASB223 and BASB224 polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are diagnostic, prophylactic and therapeutic uses.
Claims26
An isolated polypeptide comprising an amino acid sequence which has at least 85% identity to an amino acid sequence selected from the group consisting of SEQ Group 2, over the entire length of said sequence from SEQ Group 2.
An isolated polypeptide of SEQ Group 2.
An isolated polynucleotide comprising a nucleotide sequence encoding a polypeptide that has at least 85% identity to an amino acid sequence selected from SEQ Group 2 over the entire length of said sequence from SEQ Group 2;
- or a nucleotide sequence complementary to said isolated polynucleotide.
An isolated polynucleotide comprising a nucleotide sequence that has at least 85% identity to a nucleotide sequence encoding a polypeptide selected from SEQ Group 2 over the entire coding region;
- or a nucleotide sequence complementary to said isolated polynucleotide.
An isolated polynucleotide which comprises a nucleotide sequence which has at least 85% identity to a DNA sequene selected from SEQ Group 1 over the entire length of said sequence from SEQ Group 1;
- or a nucleotide sequence complementary to said isolated polynucleotide.
An isolated polynucleotide comprising a nucleotide sequence encoding a polypeptide selected from SEQ Group 2.
An isolated polynucleotide comprising a polynucleotide selected from SEQ Group 1.
An isolated polynucleotide comprising a nucleotide sequence encoding a polypeptide selected from SEQ Group 2 obtainable by screening an appropriate library under stringent hybridization conditions with a labeled probe having the corresponding DNA sequence of SEQ Group 1 or a fragment thereof.
Dependencies are inferred from the claim text.